BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, May 7, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 29, 2012
View Archived Issues
Chugai Pharmaceutical reflects on milestones of 2011
Read More
Modified gold nanoparticles display potent anticoagulant activity
Read More
Phase II trial assesses safety paclitaxel/everolimus combination in advanced urothelial cancer
Read More
New cognition-enhancing serotonin 5-HT6 receptor antagonist discovered at Cephalon
Read More
AnaptysBio describes new antibodies targeting IL-17
Read More
Merck & Co. patents novel products with potential to prevent herpes zoster
Read More
Novel 5-lipoxygenase inhibitors disclosed by Ranbaxy Laboratories
Read More
Medexis reports new products with potential to treat cancer
Read More
New cyclopropylamine derivatives designed at Oryzon Genomics
Read More
Wakunaga and NeuGen Pharma present new agents for neurological disorders
Read More
Zalicus compounds show promise as therapies for absence seizures
Read More
Selventa enters new collaboration
Read More
Alimera Sciences and pSivida provide update on Iluvien
Read More
BioDelivery Sciences and FDA agree on BEMA-buprenorphine/naloxone development plan
Read More
Proteonomix gives update on UMK-121 study
Read More
Bioheart selects site for ANGEL trial
Read More
Phase III trials of 6-month anticancer depot begin in Japan
Read More
OncoSec initiates treatment in phase II trial in metastatic melanoma
Read More
Antisense Therapeutics to form joint venture for development of ATL-1102
Read More
Lundbeck acquires remaining rights to ischemic stroke treatment candidate
Read More
New RaQualia product set to enter clinical development
Read More
FDA revises labeling for statins
Read More
Samsung Biologics and Biogen Idec form joint venture
Read More
Abbott enters global agreement for novel JAK1 inhibitor
Read More
